Figure 2.
No detectable role of blood-borne tissue factor in whole blood TG. (A-D) TG in whole blood or PRP was triggered with vehicle medium (A,C) or Rvv-X activator (dilution, 1e–6) (B,D). Where indicated, samples were pretreated with CRP-XL (25 μg/mL) and/or factor VIIai (FVIIai, 1 μg/mL). Given are representative TG curves (n = 3) as well as the curve parameters lagtime (E) and thrombin peak level (F). Means ± standard deviation (SD) (n = 3), 2-way ANOVA. ns, no statistical significance. WB, whole blood.

No detectable role of blood-borne tissue factor in whole blood TG. (A-D) TG in whole blood or PRP was triggered with vehicle medium (A,C) or Rvv-X activator (dilution, 1e–6) (B,D). Where indicated, samples were pretreated with CRP-XL (25 μg/mL) and/or factor VIIai (FVIIai, 1 μg/mL). Given are representative TG curves (n = 3) as well as the curve parameters lagtime (E) and thrombin peak level (F). Means ± standard deviation (SD) (n = 3), 2-way ANOVA. ns, no statistical significance. WB, whole blood.

Close Modal

or Create an Account

Close Modal
Close Modal